BRAMPTON, Ontario--(BUSINESS WIRE)--Taro Pharmaceuticals Inc. has initiated a voluntary Type 1 recall to the patient level on six (6) lots of Taro-Zoledronic Acid Injection, 5 mg/100 mL in 100 mL ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved zoledronic acid injection as the first therapy to treat postmenopausal osteoporosis for two ...

Please provide your email address to receive an email when new articles are posted on . A single injection of zoledronic acid was an effective prevention strategy for osteoporosis in postmenopausal ...

BALTIMORE – A single annual injection with zoledronic acid (Zometa, Novartis) is safe and effective for boosting skeletal integrity in a population of women who are most at risk for fractures and ...